Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Signs MOU to Mine High Grade Zone 2 at Cam Copper Mine (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Isodiol International Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by Nattydread26on Nov 16, 2017 1:39pm
174 Views
Post# 26978184

RE:just did this comparison

RE:just did this comparison
bambambigelo wrote: aphria 5/2017 quarterly report 6 mil rev current price 8.56. Aurora 6/2017 quarterly report 6 mil current price 5.67. cannimed 6/2017 quarterly report 6 million current price 18.94. ISODIOL 6/2017 REPORT 3 MILLION CURRENT PRICE .55, SEEMS EXTREMELY LOW COMPARED TO ITS PEERS. millions aph 5/2017 6 8.56 acb 6/201765.67 Cannimed 2017/06 6 18.94 at 10.05 am ISOdiol 2017/06 3 . 510.04 am pacific And the story becomes even more apparent when you take into consideration FV, Isodiol way under based on the above compiled using data on stockhouse


Seems like you're comparing apples to oranges. Isodiol isn't an LP so you cant really compare share price and revenue. The LP's you named have future expansion plans which in place which the share price is most likely partially baked in. Compare it to other companies who make CBD based product.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse
Later
Participate
Not interested